Funding opportunities
2,259 live opportunities from Grants.gov, NIH, NSF, and more.
Biomedical & Health× remove
- Untangling the Inner Workings of the Mycobacterial Cell EnvelopeNational Institute of General Medical SciencesPAR-22-180 closes 5/31/2031up to $432,892activenih
- Blood-based early detection of viral precancersNational Cancer InstitutePA-25-301 closes 5/31/2031up to $642,406activenih
- RNA editing dysregulation in the pathogenesis of Dementia and Parkinson’s diseaseNational Institute of Neurological Disorders and StrokePA-25-301 closes 5/31/2031up to $634,938activenih
- Creating cancer-specific genotoxicity by targeting Cas9 nickase to focal gene amplificationsNational Cancer InstitutePA-25-301 closes 5/31/2031up to $622,611activenih
- Physical and Functional Improvement via Cancer Rehabilitation Triaging (PIVOT) TrialNational Cancer InstitutePAR-25-167 closes 5/31/2031up to $544,080activenih
- Elucidating the impacts of body composition and physical activity on anti-tumor immunity and cancer control in advanced stage high-grade serous carcinomaNational Cancer InstitutePA-25-301 closes 5/31/2031up to $713,312activenih
- Investigating Mitochondrial DNA as a Biomarker and Therapeutic Target in Chronic Kidney DiseaseNational Institute of Diabetes and Digestive and Kidney DiseasesPA-24-175 closes 5/31/2031up to $148,596activenih
- Analysis of innate responses and vaccination-induced serotype-specific B and T cell responses associated with protection against controlled human dengue virus challengeNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $766,437activenih
- Changing the natural history of pancreatic ductal adenocarcinoma with cancer interception strategiesNational Cancer InstitutePAR-25-081 closes 5/31/2031up to $658,033activenih
- Controlling tumor-infiltrating regulatory T cell function by the IL-17-Ybx1 signaling pathwayNational Cancer InstitutePA-25-301 closes 5/31/2031up to $484,918activenih
- Molecular Imaging of the Immune-Suppressive TME in Prostate CancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $477,674activenih
- One-ended Break Repair in Mammalian CellsNational Cancer InstitutePA-25-301 closes 5/31/2031up to $524,110activenih
- Mechanisms of Xist-Mediated T cell AutoimmunityNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $776,226activenih
- Vaginal estradiol versus moisturizer to improve postmenopausal vaginal aging symptoms, dysbiosis and markers of HIV latency reversal in menopausal women living with HIVNational Institute on AgingPA-25-305 closes 5/31/2031up to $706,734activenih
- Spatial and Temporal control of gene therapy in CAR-T cells with ionizing radiation to improve local and distant control of solid tumorsNational Cancer InstitutePA-25-301 closes 5/31/2031up to $651,674activenih
- Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children with DisabilitiesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-305 closes 5/31/2031up to $640,699activenih
- Transcriptional and post-transcriptional drivers of MelanomaNational Cancer InstitutePA-25-301 closes 5/31/2031up to $534,325activenih
- UBE2N/UBE2V1 as a vulnerable link between keratinocytes and myeloid cellsNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPA-25-301 closes 5/31/2031up to $385,460activenih
- The Role of Estrogen Receptor in Regulating Breast Cancer Cell InvasionNational Cancer InstitutePA-25-301 closes 5/31/2031up to $544,929activenih
- Understanding the Implications of EP300 deficiency in Adult T-Cell Leukemia/LymphomaNational Cancer InstitutePA-25-301 closes 5/31/2031up to $672,960activenih
- Elucidate the mechanism of targeting MTR to enhance anti-tumor immunity in KRAS-driven lung cancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $516,808activenih
- Computational Approaches to Reconstruct the Evolutionary History of Cancer MetastasesNational Cancer InstitutePA-25-301 closes 5/31/2031up to $688,073activenih
- Systemic Sclerosis Interstitial Lung Disease Risk Factors, Prediction, and Plasma Biomarker EvaluationNational Heart Lung and Blood InstitutePA-24-182 closes 5/31/2031up to $166,520activenih
- UC Davis NEURO ProgramNational Institute of Neurological Disorders and StrokePAR-24-204 closes 5/31/2031up to $126,845activenih
- Establishing the role of hypomorphic BRCA1 and BRCA2 variants in cancer risk, etiology and response to therapyNational Cancer InstitutePA-25-301 closes 5/31/2031up to $741,738activenih